Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNK | O75909 | 17/20 | 0.63 |
| ▸ | CDK12 | Q9NYV4 | 17/20 | 0.63 |
| ▸ | CCNT1 | O60563 | 15/20 | 0.63 |
| ▸ | CCNE1 | P24864 | 15/20 | 0.63 |
| ▸ | CDK2 | P24941 | 15/20 | 0.63 |
| ▸ | CDK9 | P50750 | 15/20 | 0.63 |
| ▸ | CDK7 | P50613 | 11/20 | 0.63 |
| ▸ | CCNH | P51946 | 11/20 | 0.63 |
| ▸ | MNAT1 | P51948 | 7/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28817272 | 0.98 | CCNK (0.63) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL28817273 | 0.98 | CCNK (0.63) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL25597589 | 0.92 | CCNK (0.65) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL25594622 | 0.90 | CCNK (0.52) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL24588150 | 0.90 | CCNK (0.55) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL28817285 | 0.90 | CCNK (0.66) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL28817289 | 0.90 | CCNK (0.66) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL25594677 | 0.89 | CCNK (0.49) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL30204055 | 0.89 | CCNK (0.69) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL25594623 | 0.88 | CCNK (0.48) | CCNKCDK12CCNT1CCNE1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022134642-A1 | AROMATIC HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 湃隆生物科技有限公司（香港） | 2022-06-30 | — | — | WO | disclosed |